Search Within

CTCR Scholars

  1. "Marcel Van Den Brink"
Formats
  1. Meeting Abstract (89)
  2. Journal Article (35)
  3. Research Letter (3)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (128)
  2. Department of Medicine (128)
  3. Executive Committee, Center for Hematologic Malignancies (128)
  4. GSK Faculty (128)
  5. Hematologic Malignancies, Division of (128)
  6. Immunology Program Faculty (128)

More Groups

People
  1. Marcel Van Den Brink (128)
  2. Sergio Giralt (103)
  3. Miguel-Angel Perales (93)
  4. Doris Ponce (90)
  5. Juliet Barker (70)
  6. Jonathan Peled (61)

More People

Years
  1. 2024 (3)
  2. 2023 (11)
  3. 2022 (16)
  4. 2021 (10)
  5. 2020 (13)
  6. 2019 (15)

More Years

Publications
  1. Blood (46)
  2. Biology of Blood and Marrow Transplantation (40)
  3. Bone Marrow Transplantation (11)
  4. Journal of Clinical Oncology (5)
  5. Clinical Lymphoma, Myeloma and Leukemia (4)
  6. Science Translational Medicine (3)

More Publications

Publishers
  1. American Society of Hematology (48)
  2. Elsevier Inc. (45)
  3. Nature Publishing Group (16)
  4. American Society of Clinical Oncology (5)
  5. American Association for the Advancement of Science (4)
  6. American Association for Cancer Research (2)

More Publishers

Results (128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease
    Journal Article

    Hayase, E.; Hayase, T.; Mukherjee, A.; Stinson, S. C.; Jamal, M. A.; Ortega, M. R.; Sanchez, C. A.; Ahmed, S. S.; Karmouch, J. L.; Chang, C. C.; more...
    Cell Host & Microbe (2024)

    Fulltext@MSK | Save
  • Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT)
    Meeting Abstract

    Ponce, D. M.; Pandian, S.; van den Brink, M. R. M.; Kosuri, S.; Khera, N.; DeFilipp, Z. M.; Tejura, B.; Lichter, D. I.; Chafee, M.; Bardhan, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation
    Meeting Abstract

    Ponce, D. M.; Kosuri, S.; Khera, N.; Defilipp, Z.; Lichter, D. I.; Peled, J. U.; van den Brink, M. R. M.; Brady, K.; Puhl, M. D.; Glick, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of investigational microbiome therapeutic SER-155 on pathogen domination: Initial results from a phase 1b study in adults undergoing allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Peled, J. U.; van den Brink, M. R. M.; Ponce, D. M.; Kosuri, S.; Khera, N.; DeFilipp, Z.; Tejura, B.; Lichter, D. I.; Lombardo, M. J.; Wortman, J. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Tejura, B.; Kosuri, S.; Khera, N.; DeFilipp, M. Z.; Lombardo, M. J.; Ford, C.; Peled, J. U.; van den Brink, M. R. M.; von Moltke, L.; Ponce, D. M.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save